8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2021 / Interventional trial and metagenomic reanalysis
Researchers analyzed gut metagenomes from healthy antibiotic-naïve humans supplemented with an 11-probiotic-strain preparation, alongside mouse models and a separate human cohort receiving antibiotics. Probiotics reduced the number of antibiotic resistance genes exclusively in the gut of colonization-permissive, antibiotic-naïve individuals. Following antibiotics, probiotics exacerbated resistome expansion in GI mucosa by supporting a bloom of strains with vancomycin resistance genes, unlike autologous fecal microbiome transplantation or spontaneous recovery. These mucosal effects were not reflected in stool samples.
Montassier E, Valdés-Mas R, Batard E, et al. Nat Microbiol, 2021. PMID 34226711
2020 / Crossover feeding trial
Thirteen healthy young men consumed a control diet for 2 weeks followed by 5 days of an isocaloric high-fat diet (HFD; 55% fat, 25% saturated). Intestinal permeability and responses to a high-fat meal challenge were evaluated before and after the HFD. Intestinal permeability was not affected by the HFD (p > 0.05), but fasting endotoxin increased two-fold (p = 0.04). Skeletal muscle glucose and fatty acid oxidation increased post-meal before the HFD (+97% and +106%) but decreased post-meal after the HFD (-24% and +16%, respectively), while insulin sensitivity remained unchanged.
Bowser SM, McMillan RP, Boutagy NE, et al. Metabolism, 2020. PMID 31785256
2020 / Crossover clinical trial
In a crossover clinical trial comparing extra virgin olive oil with canola oil, 32 of 40 patients with ulcerative colitis completed two 20-day intervention rounds. Consumption of extra virgin olive oil was followed by significant decreases in erythrocyte sedimentation rate (p = 0.03) and high-sensitivity C-reactive protein (p < 0.001). Bloating, constipation, fecal urgency, incomplete defecation, and final gastrointestinal symptom rating scale scores were also significantly reduced after extra virgin olive oil consumption (p < 0.05).
NANO counterpoint →
Morvaridi M, Jafarirad S, Seyedian SS, et al. Eur J Clin Nutr, 2020. PMID 31901082
2020 / Randomized double-blind placebo-controlled pilot trial
In a 12-week pilot trial, 24 adults with obesity and mild-moderate insulin resistance were randomized to weekly oral FMT capsules from healthy lean donors or placebo for 6 weeks. There were no statistically significant improvements in insulin sensitivity between groups (+5% ± 12% in FMT vs -3% ± 32% in placebo, mean difference 9%, 95% CI -5% to 28%, p = 0.16). Additionally, no significant differences were seen for HOMA-IR (mean difference 0.2, 95% CI -0.9 to 0.9, p = 0.96), lean mass (mean difference -0.1 kg, p = 0.87), or fat mass (mean difference 1.2 kg, p = 0.18). Variable bacterial engraftment persisted throughout 12 weeks with no serious adverse events related to FMT.
Yu EW, Gao L, Stastka P, et al. PLoS Med, 2020. PMID 32150549
2020 / Randomized controlled trial
A randomized controlled trial evaluated 90 adults with functional constipation assigned to receive either 50 g/day flaxseed flour (n=60) or 15 mL/day lactulose solution (n=30) for 4 weeks. Both groups showed significant improvements in bowel habits. Median Wexner constipation scores fell from 14 to 6.5 in the flaxseed group and 15 to 9 in the lactulose group (both p<0.001). Median weekly defecation frequency rose from 2 to 7 with flaxseed and 2 to 6 with lactulose (both p<0.001), while constipation quality of life scores dropped by -1.34 and -0.66, respectively (both p<0.001).
Sun J, Bai H, Ma J, et al. Asia Pac J Clin Nutr, 2020. PMID 32229443
2019 / Randomized controlled trial
In a 4-week trial of 120 healthy adults, consuming 80 g/d or 120 g/d of prunes led to significantly greater increases in daily stool weight (+22.2 g/d and +32.8 g/d, respectively) versus control (-0.8 g/d, P = 0.026). Stool frequency was also significantly higher (P = 0.023), with increased Bifidobacteria across groups (P = 0.046) and increased flatulence. Prunes showed no effect on whole gut transit time, short-chain fatty acids, or stool pH.
Lever E, Scott SM, Louis P, et al. Clin Nutr, 2019. PMID 29398337
2019 / Randomized controlled trial
In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).
Iven J, Biesiekierski JR, Zhao D, et al. Nutr Neurosci, 2019. PMID 29607741
2019 / Randomized controlled trial
In a randomized trial, 150 patients with constipation-predominant irritable bowel syndrome consumed flixweed, fig, or control interventions for 4 months. Both flixweed and fig led to significant improvements in pain frequency, distention, defecation frequency, hard stool, quality of life, and bowel habit satisfaction compared to control. Neither intervention significantly altered C-reactive protein concentrations or the intensity of abdominal pain.
Pourmasoumi M, Ghiasvand R, Darvishi L, et al. Explore (NY), 2019. PMID 30318190
2019 / Prospective crossover study
A prospective crossover study tracked real-time bowel movement data in 52 volunteers over 4 weeks (2 weeks without a defecation postural modification device [DPMD] followed by 2 weeks with DPMD). Across 1119 recorded bowel movements, utilizing the DPMD resulted in increased bowel emptiness (OR 3.64; 95% CI, 2.78-4.77) and reduced straining (OR 0.23; 95% CI, 0.18-0.30). Furthermore, not using the DPMD was associated with increased bowel movement duration (fold increase 1.25; 95% CI, 1.17-1.33).
Modi RM, Hinton A, Pinkhas D, et al. J Clin Gastroenterol, 2019. PMID 30346317
2019 / Clinical trial
Researchers evaluated isotope-labeled l-carnitine and gamma-butyrobetaine metabolism in 40 omnivores and 32 vegans or vegetarians. Following oral d3-l-carnitine, omnivores generated over 20-fold more d3-TMAO than vegans or vegetarians (P = 0.001), despite comparable fasting plasma carnitine levels. Gut bacteria transformed carnitine into gamma-butyrobetaine in both dietary groups, but conversion of gamma-butyrobetaine to TMA was induced by chronic carnitine intake and omnivorous habits.
Koeth RA, Lam-Galvez BR, Kirsop J, et al. J Clin Invest, 2019. PMID 30530985
2019 / Three-group randomized crossover trial
Researchers evaluated the acute effects of two energy- and macronutrient-matched meals—a vegan meal with tofu (V-meal) versus a processed-meat and cheese meal (M-meal)—in men with type 2 diabetes, obese men, and healthy men (n=20 each). Postprandial GLP-1 secretion increased after the V-meal in diabetic men (by 30.5%) and healthy men (by 15.8%), while amylin increased across all groups (diabetic by 15.7%, obese by 11.5%, healthy by 13.8%). Postprandial PYY increased significantly only in healthy men (by 18.9%). Satiety was higher after the V-meal in all groups: by 9% in diabetic, 18.7% in obese, and 25% in healthy men.
Klementova M, Thieme L, Haluzik M, et al. Nutrients, 2019. PMID 30642053
2019 / Single-blinded randomized controlled trial
In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.
Soltanian N, Janghorbani M Clin Nutr ESPEN, 2019. PMID 30661699
2019 / Two randomized, placebo-controlled, double-blind trials
Two randomized, placebo-controlled, double-blind trials evaluated 7 days of psyllium versus maltodextrin placebo in 8 healthy volunteers and 16 constipated patients. In healthy adults, psyllium had a small effect on microbiota (increasing Veillonella and decreasing Subdoligranulum), while constipated patients showed greater changes (increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella, and Sutterella; decreased uncultured Coriobacteria and Christensenella) and altered acetate and propionate levels. Furthermore, increases in three butyrate-producing genera (Lachnospira, Roseburia, and Faecalibacterium) correlated with increased faecal water.
Jalanka J, Major G, Murray K, et al. Int J Mol Sci, 2019. PMID 30669509
2019 / Randomized controlled trial
A 6-month feeding trial assigned 217 healthy young adults to lower-fat (20% energy), moderate-fat (30%), or higher-fat (40%) diets. The lower-fat diet was associated with increased alpha-diversity (p = 0.03) and higher abundance of Blautia and Faecalibacterium. Conversely, the higher-fat diet was associated with decreased total short-chain fatty acids (p < 0.001), reduced Faecalibacterium, enriched fecal arachidonic acid, and higher plasma proinflammatory markers.
Wan Y, Wang F, Yuan J, et al. Gut, 2019. PMID 30782617
2019 / Randomized controlled trial
In a randomized trial, 214 adults with Crohn's disease in remission consumed either at least two weekly servings of red or processed meat (n = 118) or maximum one monthly serving (n = 96) for 49 weeks. Symptomatic relapse occurred in 62% of the high-meat participants and 42% of the low-meat cohort. Time to any relapse (P = 0.61) or moderate-to-severe relapse (P = 0.50) did not vary significantly between the dietary arms.
NANO counterpoint →
Albenberg L, Brensinger CM, Wu Q, et al. Gastroenterology, 2019. PMID 30872105
2019 / Two-year follow-up of an open-label clinical trial
Researchers conducted a two-year follow-up of 18 participants with Autism Spectrum Disorders who previously completed an open-label trial of Microbiota Transfer Therapy (MTT) combining antibiotics, bowel cleanse, acid suppressant, and fecal microbiota transplant. Most improvements in gastrointestinal symptoms were maintained, and autism-related symptoms improved further two years after treatment ended. Important gut microbiota changes persisted, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella.
Kang DW, Adams JB, Coleman DM, et al. Sci Rep, 2019. PMID 30967657
2019 / Single-group trial / case series
A lacto-ovo-semivegetarian regimen was integrated into induction therapy for 92 patients hospitalized with ulcerative colitis. Cumulative relapse rates were 14% at 1 year and 27% at 5 years for initial episode cases, and 36% at 1 year and 53% at 5 years for relapse cases. At a mean follow-up of 6 years and 4 months, adherence measured by the plant-based diet score remained significantly higher than baseline (p < 0.0001).
Chiba M, Nakane K, Tsuji T, et al. Perm J, 2019. PMID 31050638
2019 / Prospective endoscopic challenge study
A prospective study challenged 155 patients with IBS using 4 common food components via endoscope followed by confocal laser endomicroscopy (CLE), alongside duodenal biopsy and fluid analysis. Of the 108 patients who completed the study, 76 (70%) had a response to food (CLE+), with 61% of these reacting to wheat. CLE+ patients had significantly higher intraepithelial lymphocytes (P = .001), up-regulated claudin-2 (P = .023), lower occludin levels (P = .022), increased eosinophil degranulation, and higher eosinophilic cationic protein in duodenal fluid (P = .03) compared to controls. Inflammatory cytokine messenger RNA levels remained unchanged after challenge.
Fritscher-Ravens A, Pflaum T, Mösinger M, et al. Gastroenterology, 2019. PMID 31100380
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / Prospective intervention study with a matched control group
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132
2018 / Crossover trial
Eight non-heat-acclimated humans ran for 60 minutes in hot conditions after 3 days of 500 mg/day curcumin or placebo. Intestinal fatty acid-binding protein increased less with curcumin (18% to 58%) than placebo (33% to 87%). Placebo triggered significant rises in TNF-α and IL-10 (P < 0.01), whereas curcumin prevented significant changes. Curcumin also lowered the physiological strain index between 40 and 60 minutes of exercise (P < 0.01).
Szymanski MC, Gillum TL, Gould LM, et al. J Appl Physiol (1985), 2018. PMID 28935827
2018 / Randomized crossover trial
In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.
Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493
2018 / Double-blind, randomized, placebo-controlled trial
A double-blind, randomized, placebo-controlled trial evaluated the efficacy of Amla (Phyllanthus emblica L.) tablets in 68 patients with non-erosive reflux disease. Participants took two 500 mg Amla tablets or placebo twice daily after meals for 4 weeks. Heartburn and regurgitation frequencies significantly dropped in both groups (P < 0.001), but repeated measures logistic regression demonstrated a significantly greater reduction in the frequency and severity of both heartburn and regurgitation in the Amla group compared to placebo (P < 0.001).
Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. J Integr Med, 2018. PMID 29526236
2018 / Randomized controlled trial
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220